Medicare Enrolled
Dr. Scott McFerren, M.D.
Urology Physician · Dallas, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. McFerren from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McFerren?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. McFerren
Dr. Scott McFerren is an urology physician in Dallas, TX, with 10 years of NPI registration. Based on federal Medicare data, Dr. McFerren performed 1,841 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. McFerren received a total of $6,489 from 46 pharmaceutical and/or device companies across 188 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. McFerren is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 10 years of NPI registration
▲ 1,841 Medicare services
$6,489 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,841
Medicare services
Bottom 49% in TX for urology physician
Not available
Unique patients (not deduplicated)
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
420 | $2 | $5 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
327 | $95 | $259 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
177 | $67 | $183 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
168 | $8 | $16 |
| Urine culture, bacterial identification A laboratory test that grows and identifies bacteria from a urine sample to detect infections. |
132 | $8 | $16 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
122 | $8 | $22 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
88 | $117 | $336 |
| Bacterial culture, aerobic A laboratory test that grows and identifies bacteria capable of surviving in oxygen. The results help determine the presence of specific aerobic microorganisms. |
81 | $8 | $16 |
| Antibiotic sensitivity test A laboratory test that determines which antibiotics, antifungals, or antivirals are effective against a specific microorganism using microdilution or agar dilution methods. |
78 | $8 | $17 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
61 | $8 | $16 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
49 | $187 | $496 |
| PSA test (prostate cancer screening) | 37 | $18 | $37 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
26 | $58 | $156 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
21 | $48 | $126 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
18 | $104 | $261 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
12 | $260 | $651 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
12 | $113 | $283 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
12 | $145 | $362 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.7% high complexity
7.3% medium
92.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,489
Total received (2018-2024)
Avg $1,082/year across 6 years
Top 31% in TX for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
188
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,957
2023
$1,010
2022
$3,090
2021
$256
2019
$60
2018
$116
Payments by company (2024)
Sumitomo Pharma America, Inc.
$314
PROCEPT BioRobotics Corporation
$217
Boston Scientific Corporation
$204
Dendreon Pharmaceuticals LLC
$168
Merck Sharp & Dohme LLC
$136
Olympus America Inc.
$131
Astellas Pharma US Inc
$107
Janssen Biotech, Inc.
$103
Ferring Pharmaceuticals Inc.
$102
Tempus AI, Inc
$74
Verity Pharmaceuticals Inc.
$68
COLOPLAST CORP
$51
Antares Pharma, Inc.
$49
Endo USA, Inc.
$39
Novartis Pharmaceuticals Corporation
$33
UROGEN PHARMA, INC.
$28
Bayer Healthcare Pharmaceuticals Inc.
$27
Innovation Technologies Inc
$24
Integra LifeSciences Corporation
$22
Cook Medical LLC
$21
Endo Pharmaceuticals Inc.
$21
PROGENICS PHARMACEUTICALS, INC.
$17
Top 3 companies account for 37.6% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$2,451
Sumitomo Pharma America, Inc.
$478
Astellas Pharma US Inc
$387
Merck Sharp & Dohme LLC
$309
Janssen Biotech, Inc.
$282
Dendreon Pharmaceuticals LLC
$271
PROCEPT BioRobotics Corporation
$256
Olympus America Inc.
$168
ABBVIE INC.
$142
Axonics, Inc.
$131
Myovant Sciences Inc.
$119
Verity Pharmaceuticals Inc.
$104
Ferring Pharmaceuticals Inc.
$102
UROVANT SCIENCES INC
$75
Tempus AI, Inc
$74
Innovation Technologies Inc
$71
Antares Pharma, Inc.
$67
Laborie Medical Technologies Corp.
$57
Bayer HealthCare Pharmaceuticals Inc.
$57
Novartis Pharmaceuticals Corporation
$55
Endo Pharmaceuticals Inc.
$54
AstraZeneca Pharmaceuticals LP
$52
UroGen Pharma, Inc.
$51
COLOPLAST CORP
$51
BioTissue Holdings, Inc.
$51
Bayer Healthcare Pharmaceuticals Inc.
$51
Coloplast Corp
$48
Tolmar, Inc.
$43
Endo USA, Inc.
$39
HealthTronics Mobile Solutions, LLC
$39
BOSTON SCIENTIFIC CORPORATION
$36
Blue Earth Diagnostics Limited
$31
Alexion Pharmaceuticals, Inc.
$30
Progenics Pharmaceuticals, Inc.
$28
UROGEN PHARMA, INC.
$28
Clinical Laserthermia Systems Americas Inc.
$26
Integra LifeSciences Corporation
$22
Cook Medical LLC
$21
Telix Pharmaceuticals
$19
Sun Pharmaceutical Industries Inc.
$18
Foundation Medicine, Inc.
$18
Ethicon US, LLC
$17
PROGENICS PHARMACEUTICALS, INC.
$17
Teleflex LLC
$17
Provepharm Inc.
$14
Acerus Pharmaceuticals Corporation
$12
Top 3 companies account for 51.1% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · ADVANCE · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · AdVance XP · Altis · Axonics · Axumin · BIOFIX · BLUDIGO · BOTOX · Bulkamid · ELIGARD · ERLEADA · Echelon Flex · FOUNDATIONONE CDX · Flexiva · GEMTESA · GENERAL THERAPIES · GENERAL ERECTILE DYSFUNCTION · General - Erectile Dysfunction · General - Kidney Stone Disease · ILLUCCIX · IRRISEPT · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LithoVue · MOBILE LASER UNIT · Mobile Laser Services · Myrbetriq · NEOX · NOCDURNA · Natesto · Nubeqa · OES CYSTONEPHROFIBERSCOPE · ORGOVYX · Olympus · PLUVICTO · PROVENGE · PYLARIFY · RESONANCE · Rezum Generator · TACTRA · Titan · Trelstar · UROLIFT · XIAFLEX · XTANDI · XYOSTED · Xtandi · YONSA · iTIND System · rezum Generator
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
138
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
MEDICAL CITY DALLAS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. McFerren is a clinical cardiology specialist, with moderate Medicare volume.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. McFerren experienced with automated urinalysis?
Based on Medicare claims data, Dr. McFerren performed 420 automated urinalysis services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. McFerren receive payments from pharmaceutical companies?
Yes. Dr. McFerren received a total of $6,489 from 46 companies across 188 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McFerren's costs compare to other urology physicians in Dallas?
Dr. McFerren's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McFerren) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Dallas
Browse urology physicians in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Sumitomo Pharma America, Inc. Payments to Doctors
See all physicians who received payments from Sumitomo Pharma America, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology